Levofloxacino Altan

Levofloxacin, the active ingredient in Levofloxacino Altan, is a fluoroquinolone antibiotic presented as an injection for intravenous use. It treats a range of bacterial infections in adult patients, including community‑acquired pneumonia, complicated urinary tract infections, intra‑abdominal infections, skin and soft‑tissue infections, and acute bacterial sinusitis.

GNH USA supplies Levofloxacino Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacino Altan is a fluoroquinolone antibacterial used for several serious bacterial infections. - Community‑acquired pneumonia: achieves bacterial eradication and clinical cure in adult patients. - Complicated urinary tract infections: eliminates pathogenic organisms causing upper and lower urinary tract disease. - Complicated intra‑abdominal infections: provides broad‑spectrum coverage for mixed aerobic and anaerobic flora. - Skin and soft‑tissue infections: resolves cellulitis, abscesses and other bacterial skin conditions. - Acute bacterial sinusitis: clears sinus pathogens and relieves symptoms.

Levofloxacino Altan may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: occasional vertigo or light‑headedness. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in ALT/AST.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile infection: colitis with watery diarrhea. - Peripheral neuropathy: sensory disturbances, tingling. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin reactions.

Levofloxacino Altan requires careful patient assessment before use. - Renal impairment: dose adjustment may be needed based on creatinine clearance. - History of tendon disorders: avoid in patients with prior tendon injury. - Cardiac arrhythmias: monitor QT interval in patients with known prolongation. - Concomitant CNS disorders: use cautiously in patients with seizures. - Pregnancy and lactation: safety not established; avoid unless clearly needed. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacino Altan can interact with several medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption. - Warfarin: may increase INR and bleeding risk. - Theophylline: elevated plasma levels can cause toxicity. - Cyclosporine: increased cyclosporine concentrations. - NSAIDs: heightened risk of CNS stimulation and seizures.

Moderate Interactions (Monitor Closely): - Corticosteroids: increased chance of tendon rupture. - Oral contraceptives: reduced hormonal efficacy. - Diabetic agents: potential for hypoglycemia. - QT‑prolonging drugs (e.g., macrolides): monitor cardiac rhythm. - Diuretics: may enhance hypokalemia, affecting cardiac safety.